http://www.huntbiosciences.com HUNT Biosciences http://www.huntbiosciences.com/upload/rssfeed/rssfeed.xml Fuse Web Editor 2.0 http://www.huntbiosciences.com/default.asp?InnholdID=42 HUNT Biosciences Signs Collaboration Agreement with Tissue Solutions Levanger, April 14, 2010.HUNT Biosciences AS, the specialized biomarker discovery and validation company, today announced that it had signed a collaboration agreement with Tissue Solutions Ltd, a leading international supplier of biological samples for the pharmaceutical and diagnostics industry. The collaboration aims to http://www.huntbiosciences.com/default.asp?InnholdID=40 HUNT Biosciences – role model for a proposed National Biobank company in Norway In a report released the 5th of January 2010 the Research Council of Norway (RCN) refers to HUNT Biosciences as a role model for a proposed future national Biobank Company. The report was ordered by the Norwegian Ministry of Education and Research, and the Ministry of Health and Care Services. Large amounts of http://www.huntbiosciences.com/default.asp?InnholdID=7 The General Assembly of HUNT Biosciences have on October 15 agreed to invest additional NOK 9 mill in the company. The investment is made by the current owners; NTNU, Helse Midt-Norge and North Trøndelag County and will allow the company to initiate projects with industry partners in the area of Pharmacogenomics and health economy. http://www.huntbiosciences.com/default.asp?InnholdID=37 Technology transfer specialists step up as business development officer with HUNT Biosciences. HUNT Biosciences, the commercial arm of the HUNT Study and associated biobank today announced the appointment of former Special Adviser Håkon Haaheim as its new BDO responsible for collaboration projects with pharmaceutical and life science industry. Haaheim has been working with development of molecu http://www.huntbiosciences.com/default.asp?InnholdID=35 On March 17th HUNT Biosciences and NTNU signed an agreement regarding use of data and samples from The North Trøndelag Health Study (HUNT). HUNT Biosciences, according to the agreement, has access to HUNT material for specific project applications. HUNT Biosciences was established in 2007 to commercialize results from HUNT. The first study was conducted in the years from 1984 to 1986 (HUNT 1) http://www.huntbiosciences.com/default.asp?InnholdID=36 HUNT Biosciences, the commercial arm of the HUNT Study and associated biobank today announced the appointment of former GE Healthcare director Per Foss as its new CEO. The company provides pharmaceutical and healthcare companies with biomarker discovery and validation services. These are based on the unique HUNT Study, which for the past 25 years has gathered blood samples from the general populat